Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Point and Frameshift Mutations

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...

Mutations

Mutations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

T-cell-targeted immunotherapy in neurofibromatosis type 2-related vestibular schwannoma: current evidence and future direction.

Brain communications·2026

Same author

Risk-reducing surgery, risk-reducing medication, and surveillance in young <i>BRCA</i> carriers with breast cancer: considering all the options.

Translational cancer research·2026

Same author

Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis.

British journal of cancer·2026

Same author

Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature.

Hereditary cancer in clinical practice·2026

Same author

A systematic review and meta-analysis of outcomes following active surveillance, surgery and radiotherapy of meningiomas in NF2-related schwannomatosis.

Neuro-oncology advances·2026

Same author

Association of Y-chromosomal gr/gr deletions with testicular germ cell tumor: whole-genome analysis of 198,306 individuals.

medRxiv : the preprint server for health sciences·2026

Same journal

COL1A1 and SERPINE1 as Potential Therapeutic Targets in Diabetic Retinopathy: A Study Incorporating RNA Transcriptomics, Single-Cell RNA Sequencing, and Proteomics.

Human mutation·2026

Same journal

Autosomal Dominant Missense <i>DAG1</i> Variant Linked to Mild-Moderate LGMD R16.

Human mutation·2026

Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026

Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026

Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026

Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 29, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Re-evaluation of missense variant classifications in NF2.

Katherine V Sadler^1,2, Charlie F Rowlands^1,2, Philip T Smith¹

¹Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester Academic Health Sciences Centre (MAHSC), Manchester, UK.

|March 25, 2022

Summary

This summary is machine-generated.

Classifying missense variants in the NF2 gene is challenging. This study analyzes NF2 variants, finding differences in their distribution across exons, suggesting potential genotype-phenotype correlations.

Keywords:

NF2 classification guidelines missense neurofibromatosis type 2 variant classification

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Experiment Videos

Last Updated: Sep 29, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Area of Science:

Genetics
Genomic Medicine
Molecular Biology

Background:

Missense variants in the NF2 gene cause variable presentations of NF2 disease.
Classifying the pathogenicity of NF2 missense variants is difficult due to limited functional and evidence-based data.

Purpose of the Study:

To summarize NF2 missense variants and classify them based on available evidence.
To investigate the distribution of NF2 missense variants across the gene and compare it with population data.

Main Methods:

NF2 missense variants were collected from pathology databases and scientific literature.
Variant classification followed the Association for Clinical Genomic Sciences Best Practice Guidelines (2020).
Variant frequencies were analyzed across NF2 exons and compared between gnomAD population data and disease-associated variants.

Main Results:

Most NF2 missense variants remain classified as variants of uncertain significance.
NF2 variants from pathology databases showed varying rates of occurrence by exon, with the highest in exon 7.
A potential genotype-phenotype correlation was suggested by differing variant frequencies between population and disease data.

Conclusions:

Further phenotypic and functional data are required for definitive NF2 missense variant interpretation.
Differences in variant distribution suggest a potential genotype-phenotype correlation in NF2 disease that warrants further investigation.